Final ID: Su1140
Galecio-castillo Milagros, Bajrami Arsida, Krug Randall, Cruz-criollo Leonardo, Kalakoti Piyush, Geyik Serdar, Ortega-gutierrez Santiago
Duration of Antiplatelet Therapy and Risk of MACE in Patients With Coronary In-Stent Restenosis Treated With Second-Generation Drug-Eluting Stents or Drug-Coated BalloonsKrefting Johannes, Ramirez Santizo Daniela, Graesser Christian, Kruger Nils, Voll Felix, Von Scheidt Moritz, Kastrati Adnan, Schunkert Heribert, Kufner Sebastian